WhiteOak Capital Multi Asset Allocation Fund
Regular Plan · IDCW Option · WhiteOak Capital Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.78% | +2.06% | 34 of 37 |
| YTD | -0.18% | -0.65% | 3 of 37 |
| INCEPTION | -4.23% | — | — |
Ranked among: Hybrid Scheme - Multi Asset Allocation.
NAV History
Portfolio
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 29.74 | 23.33 |
| P/B | 2.47 | 3.07 |
| Price / Sales | 4.30 | 3.06 |
| Price / Cash Flow | 12.75 | 16.06 |
| Dividend Yield (%) | 3.24 | 1.63 |
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
360 ONE Multi Asset Allocation Fund
Regular Plan · GROWTH Option
|
+7.58% | — | — | +14.23% |
|
Quant Multi Asset Allocation Fund
Regular Plan · IDCW Option
|
+7.57% | +19.54% | +16.29% | +12.56% |
|
Aditya Birla Sun Life Multi Asset Allocation Fund
Direct Plan · GROWTH
|
+6.92% | +16.02% | — | +15.93% |
|
Invesco India Multi Asset Allocation Fund
Regular Plan · Growth
|
+6.90% | — | — | +12.04% |
|
Mirae Asset Multi Asset Allocation Fund
Direct Plan · Growth
|
+6.72% | — | — | +12.84% |
|
HSBC Multi Asset Allocation Fund
Regular Plan · Growth
|
+6.63% | — | — | +12.02% |
|
Canara Robeco Multi Asset Allocation Fund
Direct Plan · Growth
|
+6.47% | — | — | +9.31% |
|
Edelweiss Multi Asset Allocation Fund
Direct Plan · Growth
|
+6.24% | +7.53% | — | +7.43% |
|
Mahindra Manulife Multi Asset Allocation Fund
Regular Plan · Growth
|
+4.95% | — | — | +12.37% |
|
Bank of India Multi Asset Allocation Fund
Regular Plan · IDCW
|
+4.51% | — | — | +8.06% |
More From WhiteOak Capital Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
WhiteOak Capital Pharma and Healthcare Fund
Direct Plan · Growth Option
|
+20.63% | — | — | +22.86% |
|
WhiteOak Capital Special Opportunities Fund
Direct Plan · Growth Option
|
+9.86% | — | — | +16.53% |
|
WhiteOak Capital Arbitrage Fund
Direct Plan · Growth Option
|
+7.12% | — | — | +7.24% |
|
WhiteOak Capital Mid Cap Fund
Direct Plan · Growth Option
|
+6.44% | +20.80% | — | +21.53% |
|
WhiteOak Capital Liquid Fund
Direct Plan · Growth Option
|
+6.39% | +6.80% | +6.26% | +5.63% |
|
WhiteOak Capital Ultra Short Term Fund
Direct Plan · Growth Option
|
+6.24% | +6.93% | +6.37% | +5.90% |
|
WhiteOak Capital Equity Savings Fund
Direct Plan · Growth Option
|
+5.27% | — | — | +10.73% |
|
WhiteOak Capital Multi Cap Fund
Direct Plan · Growth Option
|
+2.50% | +18.14% | — | +17.57% |
|
WhiteOak Capital Balanced Advantage Fund
Direct Plan · Growth Option
|
+1.98% | +11.98% | — | +12.76% |
|
WhiteOak Capital Balanced Hybrid Fund
Direct Plan · Growth Option
|
+1.54% | +11.10% | — | +11.27% |
About This Scheme
Investment Objective
To provide long term capital appreciation and generate income by investing in instruments across multiple asset classes viz. Equity, Debt, Gold/Silver related instruments and Exchange Traded Commodity Derivatives. There is no assurance that the investment objective of the Scheme will be achieved.
Stated Asset Allocation
Equity and Equity Related Instruments (including REITs): 10% - 80%; Debt Securities and Money Market Instruments: 10% - 80%; Gold/silver related instruments (including ETFs, Sovereign gold deposit schemes) & Exchange Traded Commodity Derivatives (ETCDs) as permitted by SEBI from time to time: 10% - 50%; Units issued by InvITs: 0% - 10%
Exit Load
Nil
Fund Managers
FM1 - Mr. Ramesh Mantri; FM2- Mr. Piyush Baranwal; FM3 - Mr. Dheeresh Pathak; FM4 - Mr. Ashish Agrawal; FM5 - Ms. Trupti Agrawal
FM1 - Comanage/Equity; FM2 - Comanage/Debt; FM3 - Assistant Fund Manager - Equity; FM4 - Fund Manager - Arbitrage Transactions; FM5 - Assistant Fund Manager - Equity
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch